The role of thioredoxin reductase 1 in melanoma metabolism and metastasis

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

(2015) James Larkin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers

(2015) Barak Rotblat et al.   Oncotarget

Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase

(2014) Zuandi Luo et al.   Metallomics

Selenoproteins: Molecular Pathways and Physiological Roles

(2014) Vyacheslav M. Labunskyy et al.   PHYSIOLOGICAL REVIEWS

Nrf2 Prevents Initiation but Accelerates Progression through the Kras Signaling Pathway during Lung Carcinogenesis

(2013) Hironori Satoh et al.   CANCER RESEARCH

Combination Molecularly Targeted Drug Therapy in Metastatic Melanoma: Progress to Date

(2013) Charlotte Lemech et al.   DRUGS

The thioredoxin antioxidant system

(2013) Jun Lu et al.   FREE RADICAL BIOLOGY AND MEDICINE

A Somatic Mutation of the KEAP1 Gene in Malignant Melanoma Is Involved in Aberrant NRF2 Activation and an Increase in Intrinsic Drug Resistance

(2013) Shinpei Miura et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

(2013) Joanna Kaplon et al.   NATURE

The Small GTPase ARF6 Stimulates  -Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis

(2013) A. H. Grossmann et al.   Science Signaling

Repurposing Approved and Abandoned Drugs for the Treatment and Prevention of Cancer through Public-Private Partnership

(2012) S. J. Weir et al.   CANCER RESEARCH

A Landscape of Driver Mutations in Melanoma

(2012) Eran Hodis et al.   CELL

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

(2012) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution

(2011) Keiko Taguchi et al.   GENES TO CELLS

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

(2011) Gina M. DeNicola et al.   NATURE

Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction

(2010) Robyn L. Poerschke et al.   BIOCHEMICAL PHARMACOLOGY

Loss of Thioredoxin Reductase 1 Renders Tumors Highly Susceptible to Pharmacologic Glutathione Deprivation

(2010) P. K. Mandal et al.   CANCER RESEARCH

ZnO Particulate Matter Requires Cell Contact for Toxicity in Human Colon Cancer Cells

(2010) Philip J. Moos et al.   CHEMICAL RESEARCH IN TOXICOLOGY

The essence of senescence

(2010) T. Kuilman et al.   GENES & DEVELOPMENT

Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study

(2010) Rosalynn M. Nazarian et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma Chemoprevention

(2009) A. G. Goodson et al.   CLINICAL CANCER RESEARCH

Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity

(2009) Matthew Honeggar et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

(2008) Adam I Riker et al.   BMC Medical Genomics

Reactive oxygen species: an Achilles’ heel of melanoma?

(2008) John P Fruehauf et al.   Expert Review of Anticancer Therapy